In situ expression of IFN-γ-inducible T cell α chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regression

By Chu Yiwei   Yang Xiuli   Xu Wei   Wang Ying   Guo Qiang   Xiong Sidong  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 10, 2007-10 ,pp. : 1539-1549

Springer Publishing Company

Access to resources Recommend Favorite

Screening a novel FGF3 antagonist peptide with anti-tumor effects on breast cancer from a phage display library

By                          

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 7051-7058

Spandidos Publications

Access to resources Recommend Favorite

SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice

By Suzuki Kensuke   Hayashi Ryuji   Ichikawa Tomomi   Imanishi Shingo   Yamada Toru   Inomata Minehiko   Miwa Toshiro   Matsui Shoko   Usui Isao   Urakaze Masaharu   Matsuya Yuji   Ogawa Hirofumi   Sakurai Hiroaki   Saiki Ikuo   Tobe Kazuyuki  

Oncology Reports, Vol. 27, Iss. 6, 2012-06 ,pp. : 1726-1732

Spandidos Publications

Access to resources Recommend Favorite

Adoptively transferred ex vivo expanded -T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer

By Beck Benjamin  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite

Fucoidan Inhibited 4T1 Mouse Breast Cancer Cell Growth In Vivo and In Vitro Via Downregulation of Wnt/β-Catenin Signaling

By Xue Meilan  

Nutrition and Cancer, Vol. 65, Iss. 3, 2013-04 ,pp. : 460-468

Routledge Ltd

Access to resources Recommend Favorite